Skip to content
akaturk Academic measurement
Sign in Register

Academician

HAKAN ÜNVER

PROFESÖR

ESKİŞEHİR TEKNİK ÜNİVERSİTESİ FEN FAKÜLTESİ KİMYA BÖLÜMÜ

  • Ana Dal Fen Bilimleri ve Matematik Temel Alanı
  • Yan Dal Kimya

A quick look at recorded outputs — details below.

  • Articles 51
  • Projects 0
  • Books 1
  • Proceedings 27
  • Patents 0
  • Artistic 0
Scopus (SJR) Q1 10 Q2 34 Q3 20 Q4 1
WoS (JCR) Q1 7 Q2 24 Q3 29 Q4 6
TR Index 2 articles

Field+year+type normalized OpenAlex percentiles — not Clarivate ESI / SciVal.

Top 1% articles 1
Top 10% articles 8
Avg percentile 61.9%
Top 1% share 1.6%
Top 10% share 12.9%

Articles

Articles with YÖKSİS and OpenAlex source split; narrow by quartile or TR Index.

Index filters

51 publications total

Scopus (SJR)
Q1 10 Q2 34 Q3 20 Q4 1
WoS (JCR)
Q1 7 Q2 24 Q3 29 Q4 6
TR Index
2 articles

Article list

  1. 2026 Conformationally adaptive benzimidazolium–chalcone hybrid salts as selective TGF-β1 inhibitors Bioorganic Chemistry DOI 10.1016/j.bioorg.2026.109911 YÖKSİS SJR Q1 JCR Q1 OpenAlex 34.2%
  2. 2026 Novel benzimidazole based cobalt complex: synthesis, AChE enzyme inhibition, antibacterial and antibiofilm activity against multidrug-resistant bacteria, and computational analysis Polyhedron DOI 10.1016/j.poly.2025.117861 YÖKSİS SJR Q3 JCR Q2 OpenAlex top 10% OpenAlex 90.2%
  3. 2026 Synthesis & biological evaluation of novel sulfonyl hydrazone derivatives Computational Biology and Chemistry DOI 10.1016/j.compbiolchem.2026.109258 YÖKSİS SJR Q2 JCR Q1 OpenAlex 72.8%
  4. 2025 Heteronuclear cadmium(II)/cobalt(III) cyanide coordination polymers with 1-methylimidazole and 1-ethylimidazole ligands: synthesis, characterization and catalytic activities Inorganica Chimica Acta DOI 10.1016/j.ica.2024.122400 YÖKSİS SJR Q2 JCR Q2 OpenAlex 54.7%
  5. 2025 New hydrazone derivatives: synthesis, characterization, carbonic anhydrase I-II enzyme inhibition, anticancer activity and in silico studies Zeitschrift für Naturforschung C DOI 10.1515/znc-2024-0226 YÖKSİS SJR Q3 JCR Q3 OpenAlex 87.6%
  6. 2025 Multifunctional benzimidazolium derivatives as anticancer, antibacterial, and acetylcholinesterase inhibitors: In vitro and molecular docking studies Archives of Biochemistry and Biophysics DOI 10.1016/j.abb.2025.110630 YÖKSİS SJR Q1 JCR Q2 OpenAlex top 10% OpenAlex 90.8%
  7. 2025 Synthesis, X-ray characterization of new copper-benzimidazole complex and investigation of its homogenous catalytic oxidation activity on selected primary and secondary alcohols Journal of Molecular Structure DOI 10.1016/j.molstruc.2024.140897 YÖKSİS SJR Q2 JCR Q2 OpenAlex 53.9%
  8. 2025 Novel vanillin-derived Schiff Bases: Synthesis, characterization, antibacterial activity, enzyme inhibition, antioxidant activity, anti-inflammatory activity on LPS-induced RAW264.7 macrophage cell line, and In Silico studies Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.142320 YÖKSİS SJR Q2 JCR Q2 OpenAlex top 1% OpenAlex 99.1%
  9. 2025 Design, synthesis, and biological evaluation of novel vanillin-derived hydrazone compounds with antimicrobial, anticancer, and enzyme inhibition activities, along with molecular structure and drug-likeness assessment Biochemical and Biophysical Research Communications DOI 10.1016/j.bbrc.2025.152173 YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 98.3%
  10. 2025 Salicylaldehyde-derived Hydrazones: Synthesis, characterization, antibacterial activity, antioxidant and anti-inflammatory effects on LPS-induced RAW264.7 macrophage cells, drug-likeness properties, and molecular docking analysis Biochemical and Biophysical Research Communications DOI 10.1016/j.bbrc.2025.151872 YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 95.1%
  11. 2025 Design, synthesis, in vitro, and in silico studies of benzimidazolium derivatives as potent antimicrobial agents Journal of Molecular Structure DOI 10.1016/j.molstruc.2025.143119 YÖKSİS SJR Q2 JCR Q2 OpenAlex 73.2%
  12. 2025 Synthesis of Thiazole-methylsulfonyl Derivatives, X-ray Study, and Investigation of Their Carbonic Anhydrase Activities: In Vitro and In Silico Potentials ACS OMEGA DOI 10.1021/acsomega.5c00509 YÖKSİS SJR Q1 JCR Q2 OpenAlex 89.8%
  13. 2025 DESIGN AND BIOLOGICAL EVALUATION OF PALLADIUM(II)PHOSPHINEBENZIMIDAZOLE COMPLEXES AS DUAL ANTIOXIDANT AND ANTIANGIOGENIC AGENTS ACS Omega DOI 10.1021/acsomega.5c04508 YÖKSİS SJR Q1 JCR Q2 OpenAlex 70.3%
  14. 2025 Synthesis of New Hydrazone Derivatives, Characterization, Single Crystal X‐Ray, Antimicrobial, SEM , and DFT Studies Chemical Biology & Drug Design DOI 10.1111/cbdd.70199 YÖKSİS SJR Q2 JCR Q3 OpenAlex 67.8%
  15. 2024 Heteronuclear Hexacyanometallate(III) Coordination Polymers (Cd/Cr, Cd/Fe, Cd/Co) with 3-(Aminomethyl)pyridine: Synthesis, Characterization, and Catalytic Activities for the Peroxidative Oxidation of Benzylic Alcohols Journal of Inorganic and Organometallic Polymers and Materials DOI 10.1007/s10904-023-02861-z YÖKSİS SJR Q2 JCR Q1 OpenAlex 47.7%
  16. 2024 Heteronuclear coordination polymers with imidazole ligand: Synthesis, characterization and alcohol oxidation activities Polyhedron DOI 10.1016/j.poly.2024.117263 YÖKSİS SJR Q3 JCR Q2 OpenAlex 43.4%
  17. 2024 Investigation of the anticancer of photodynamic therapy effects by using the novel Schiff base ligand palladium complexes on human breast cancer cell line Chemical Papers DOI 10.1007/s11696-024-03622-z YÖKSİS SJR Q2 JCR Q3 OpenAlex 88.5%
  18. 2024 Synthesis, characterization and catalytic evaluation of three new Pd-iminophosphine complexes on Suzuki cross-coupling reactions Journal of Chemical Sciences DOI 10.1007/s12039-024-02284-4 YÖKSİS SJR Q3 JCR Q3 OpenAlex 45.4%
  19. 2024 Investigation of the anticancer effect of newly synthesized palladium conjugate Schiff base metal complexes on non-small cell lung cancer cell line and mouse embryonic fibroblast cell line BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS DOI 10.1016/j.bbrc.2024.150658 YÖKSİS SJR Q2 JCR Q3 OpenAlex top 10% OpenAlex 96.2%
  20. 2024 Benzimidazole‐Containing Compounds as Anticancer Agents ChemistrySelect DOI 10.1002/slct.202401566 YÖKSİS SJR Q3 JCR Q3 OpenAlex 87.1%

Back to academicians